Next Article in Journal
Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations
Next Article in Special Issue
Leveraging Hot Spots of TEAD–Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling
Previous Article in Journal
Fabrication and Characterization of Celecoxib-Loaded Chitosan/Guar Gum-Based Hydrogel Beads
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(4), 553; https://doi.org/10.3390/ph16040553
Action Date Notes Link
article xml file uploaded 6 April 2023 11:39 CEST Original file -
article xml uploaded. 6 April 2023 11:39 CEST Update -
article pdf uploaded. 6 April 2023 11:39 CEST Version of Record https://www.mdpi.com/1424-8247/16/4/553/pdf-vor
article supplementary file uploaded. 6 April 2023 11:39 CEST - https://www.mdpi.com/1424-8247/16/4/553#supplementary
article html file updated 6 April 2023 11:41 CEST Original file -
article xml file uploaded 10 April 2023 03:15 CEST Update -
article xml uploaded. 10 April 2023 03:15 CEST Update https://www.mdpi.com/1424-8247/16/4/553/xml
article pdf uploaded. 10 April 2023 03:15 CEST Updated version of record https://www.mdpi.com/1424-8247/16/4/553/pdf
article html file updated 10 April 2023 03:16 CEST Update -
article html file updated 20 April 2023 20:47 CEST Update https://www.mdpi.com/1424-8247/16/4/553/html
Back to TopTop